Literature DB >> 8040773

Nephrocalcinosis in pseudohypoaldosteronism and the effect of indomethacin therapy.

H Shalev1, M Ohali, O Abramson.   

Abstract

We report four patients with pseudohypoaldosteronism, aged 5 months to 5 years. All patients had hypercalciuria and three had nephrocalcinosis. Two patients with nephrocalcinosis were treated with indomethacin. Polydipsia decreased and appetite and weight gain improved within 14 days of therapy. Hypercalciuria, polyuria, and creatinine clearance decreased 30% to 50% and urinary prostaglandin E2 levels decreased fourfold to eightfold.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8040773     DOI: 10.1016/s0022-3476(94)70204-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  3 in total

1.  Medullary nephrocalcinosis in nephropathic cystinosis.

Authors:  D S Theodoropoulos; T H Shawker; C Heinrichs; W A Gahl
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

2.  Critical points in the management of pseudohypoaldosteronism type 1.

Authors:  Tülay Güran; Serpil Değirmenci; İpek K Bulut; Aysun Say; Felix G Riepe; Ömer Güran
Journal:  J Clin Res Pediatr Endocrinol       Date:  2011-06-08

3.  Novel SCNN1A gene splicing-site mutation causing autosomal recessive pseudohypoaldosteronism type 1 (PHA1) in two Italian patients belonging to the same small town.

Authors:  Gregorio Serra; Vincenzo Antona; Maria Michela D'Alessandro; Maria Cristina Maggio; Vincenzo Verde; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2021-06-16       Impact factor: 2.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.